Stem Nova Network supplies USA-made umbilical cord tissue-derived mesenchymal stem cells (UCT-MSCs) and 3D-cultured exosomes, optimized for enhanced bioactivity and therapeutic efficacy. They provide these advanced cellular therapies to clinics and guide individuals to qualified therapy partners, ensuring high viability and ethical sourcing for recovery, immunity, and wellness applications.
Funding
Funding not disclosed
Founders
Product
Problem
The regenerative medicine sector faces challenges in sourcing high-viability, ethically produced cellular therapies and ensuring their effective application. This limits patient access to advanced treatments for recovery, immunity, and wellness.
Solution
Stem Nova Network provides USA-made umbilical cord tissue-derived mesenchymal stem cells (UCT-MSCs) and 3D-cultured exosomes, optimized for enhanced bioactivity and therapeutic efficacy. The company operates a dual referral model, supplying UCT-MSCs and 3D Exosome+™ directly to clinics while guiding individuals to qualified therapy partners. This approach ensures that products meet stringent viability standards (95-98%) and are sourced from rigorously screened, first-pregnancy donors. Stem Nova Network facilitates access to innovative cellular therapies aimed at supporting recovery, bolstering immunity, and promoting overall wellness.
Target Audience
The primary customers are healthcare clinics and medical professionals seeking advanced cellular therapies, as well as individuals looking for regenerative treatments to support recovery, immunity, and wellness.
Features
- Direct supplier of USA-made UCT-MSCs and 3D Exosome+™ products.
- 3D culturing technology that yields up to 20x more therapeutic factors compared to 2D methods.
- Products derived from FDA Type II DMF-registered tissue banks and compliant with 361 HCT/P regulations for investigational use.
- High cell viability rates of 95-98% for UCT-MSC products.
- Ethical sourcing from first-pregnancy donors screened to high global standards.
- Facilitates B2B referrals to clinics and B2C guidance to therapy administration partners.
- Products manufactured to injectable quality standards, labeled for topical and research use unless under physician discretion or applicable law.
- Supports applications in joint regeneration, aesthetic recovery, hair restoration, and immune support.